---
title: SARS-CoV-2 Model Development Case Study
description: This case study highlights the development of a SARS-CoV-2 mouse model with the flexiVent, an advanced preclinical pulmonary research platform.
image: https://emka.scireq.com/hubfs/covid%20animal%20model.png
---

[GET A QUOTE](http://www.scireq.com/contact-us/) [SIGN IN](http://www.scireq.com/login-register/)

[![SCIREQ](https://emka.scireq.com/hubfs/SCIREQ_August2018%20Theme/Images/scireq_logo_new.png)](https://www.scireq.com/)

# SARS-CoV-2 Mouse Model Development

**![animal+icon+mouse+blue](https://emka.scireq.com/hs-fs/hubfs/Imported_Blog_Media/animal+icon+mouse+blue.png?width=141&name=animal+icon+mouse+blue.png)**

The SCIREQ flexiVent is an advanced pulmonary research platform highly adapted to assist in covid-19 preclinical experimentation. **This case study highlights the development of a SARS-CoV-2 mouse model with the flexiVent.**

 

 

Note: Institutional firewalls may prevent downloading directly from the website. Please contact [info@scireq.com](mailto:info@scireq.com) if there are any difficulties accessing the documentation

[![SCIREQ](https://emka.scireq.com/hubfs/SCIREQ_August2018%20Theme/Images/scireq_logo_new.png)](https://www.scireq.com/)

SCIREQ Scientific Respiratory Equipment Inc.  
 Head Office : 6600 St-Urbain Suite 300 Montreal, QC H2S 3G8 Canada  
 Telephone: Toll free [1 (877) 572-4737](tel:18775724737) or [1 (514) 286-1429](tel:1%205142861429)  
[info@scireq.com](mailto:info@scireq.com)